Systemic Overexpression of the α1B‐Adrenergic Receptor in Mice: An Animal Model of Epilepsy
Open Access
- 8 November 2002
- Vol. 43 (11) , 1324-1329
- https://doi.org/10.1046/j.1528-1157.2002.13202.x
Abstract
A lack of selective alpha1-adrenergic receptor (alpha1-ARs) agonists and antagonists has made it difficult to clarify the precise function of these receptors in the CNS. We recently generated transgenic mice that overexpress either wild-type or a constitutively active mutant alpha 1B-AR in tissues that normally express the receptor. Both wild-type and mutant mice showed an age-progressive neurodegeneration with locomotor impairment and probable stress-induced motor events, which can be partially reversed by alpha 1-AR antagonists. We hypothesized that the wild-type and mutant mice may exhibit spontaneous epileptogenicity as compared with normal (nontransgenic) mice. Normal, wild-type, and mutant mice were studied. Twenty mice (1 year old) underwent prolonged video-EEG monitoring over a 4-week period. Raw EEG data were blindly analyzed by visual inspection for the presence of interictal and ictal epileptic activities. During the acute postoperative period (< or = 3 days), both wild-type (26.1 +/- 8.07 spikes/day) and mutant mice (116.87 +/- 55.13) exhibited more frequent interictal spikes than did normal mice (2.17 +/- 0.75; p value, 3 days), wild-type and mutant mice showed more frequent interictal spikes (15.44 +/- 4.07; p < 0.01; and 6.05 +/- 2.46; p < 0.05, respectively) as compared with normal mice (0.41 +/- 0.41), but only mutant mice had spontaneous clinical seizures (means +/- SEM). The selective overexpression of the alpha 1B-AR is associated with increased in vivo spontaneous interictal epileptogenicity and EEG/behavioral seizures. These results suggest a possible role (direct or indirect) for the alpha 1B-ARs in the development and expression of epileptogenicity.Keywords
This publication has 41 references indexed in Scilit:
- Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophyNature Medicine, 2000
- Cloning, Cell-Type Specificity, and Regulatory Function of the Mouse α1B-Adrenergic Receptor PromoterMolecular Pharmacology, 1999
- Potentiation of Excitotoxicity in Transgenic Mice Overexpressing Neuronal Cyclooxygenase-2The American Journal of Pathology, 1999
- Evaluation of the α 2A -adrenergic receptor gene in a heritable form of temporal lobe epilepsyNeurology, 1998
- Synergism of Constitutive Activity in α1-Adrenergic Receptor ActivationBiochemistry, 1997
- Recent advances in the molecular pharmacology of the α1-adrenergic receptorsCellular Signalling, 1996
- Strychnine-induced seizures in mice: The role of noradrenalineProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1994
- Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence for mediation by an α1 receptor-linked second messenger pathwayBrain Research, 1991
- Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic systemPublished by Elsevier ,1991
- Astroglial cells in vitro are heterogeneous with respect to expression of the α1‐adrenergic receptorGlia, 1989